Key result
Intensive BP control under 130/80 is linked to fewer complications and lower mortality versus standard targets.
Why the study?
Limited real-world evidence on the clinical benefits of intensive blood pressure management has led to poor adoption in primary care settings.
Does an intensive blood pressure target (below 130/80 mmHg) reduce hypertension related complications and all-cause mortality compared to a standard target in patients with uncomplicated hypertension?
Cohort (n=118,271)
Yes
Does an intensive blood pressure target (below 130/80 mmHg) reduce hypertension related complications and all-cause mortality compared to a standard target in patients with uncomplicated hypertension?
Intensive blood pressure management (<130/80 mmHg) in real-world primary care settings is associated with reduced hypertension-related complications and mortality without increasing serious adverse events.
Answers are grounded in this paper and cite their sources.
Supports intensive targets in uncomplicated hypertension; extends RCT evidence to real-world care but remains hypothesis-generating.
The limited real-world evidence on the clinical benefits of intensive blood pressure (BP) management demonstrated in randomised controlled trials has led to its poor adoption in primary care settings. Here we conducted a target trial emulation study on 118,271 patients with uncomplicated hypertension to evaluate the effectiveness and safety managed by intensive (below 130/80 mmHg) compared to standard (130-140/80-90 mmHg) BP targets using a territory-wide public healthcare database in Hong Kong. Patients in the intensive blood pressure target group were observed to incur a lower risk of hypertension related complications and all-cause mortality with no significant increased risk of the serious adverse events reported. The findings of this study provide evidence on the clinical benefits of an intensive BP management in real-world settings, supporting the adoption of a BP target of less than 130/80 mmHg in clinical guidelines for the treatment of adult patients with hypertension in primary care.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) conducted a cohort in Uncomplicated hypertension (n=118,271). Intensive blood pressure target (<130/80 mmHg) vs. Standard blood pressure target (130-140/80-90 mmHg) was evaluated on Hypertension related complications and all-cause mortality. Intensive blood pressure management (<130/80 mmHg) lowered the risk of hypertension-related complications and all-cause mortality compared to standard targets (130-140/80-90 mmHg).
Synapse has enriched 10 related papers. Consider them for comparative context: